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Abstract 
This review covers the applications of electron 
microscopic techniques to the characterization and evalu-
ation of drug delivery systems. Various electron micro-
scopic (EM) related techniques such as transmission 
electron microscopy, scanning electron microscopy 
(SEM), SEM with energy dispersive X-ray microanaly-
sis, and freeze-fracture electron microscopy are exten-
sively used for this purpose. Microcapsules, micro-
spheres, nanocapsules, liposomes , polymeric carriers 
and other drug delivery systems are characterized using 
EM related techniques for their surface topography, size 
and shape analysis, biodegradation, in vitro - in vivo 
evaluation and drug excipient interactions and character-
ization. Electron microscopy methods are very useful in 
understanding the mechanism of drug carrier formation, 
drug release in in vitro - in vivo situations, and drug 
carrier - body fluid interactions . EM techniques have 
also been used to study ultra-structural disposition of 
drug carriers in body compartments. 
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Introduction 
Drug use must be as old as the human race. The 
administration of drugs to the human body has been a 
constant challenge for the scientists working in health 
related fields. The two major approaches for the admin-
istration of drugs are: a). Conventional dosage forms , 
for examples: tablets, capsules, emulsions, solutions, 
etc.; and b). Controlled drug delivery systems, for 
examples : microcapsules, nanocapsules, polymeric car-
riers, liposomes, etc. 
Both approaches have two common ingredients: 
the active drug and the excipients being used to formu-
late the dosage. The broad differences between these 
two are the mechanism and site of release. These fac-
tors have played an important role in the advantageous 
applications of drug delivery systems over conventional 
dosage forms. 
In recent years, considerable attention has been 
targeted on the development of new drug delivery sys-
tems. A few of the important reasons for this extensive 
researcb on drug delivery systems by the pharmaceutical 
industry, academia, and related health scientists are: 
a) The high cost of new drug development has 
initiated research to find suitable, efficient ways of de-
livering existing drugs with a higher therapeutic effi-
ciency . 
b) The repatentability of the drug delivery sys-
tems for the existing drugs. 
c) New systems of delivery are needed for the 
transport of novel genetically engineered pharmaceuti-
cals, i.e., peptides and proteins, to their sites of action 
without incurring significant adverse immunogenical re-
sponse or biological inactivation. 
d) The targeting of very potent drugs, especially 
in cancer therapy, to avoid excessive side effects. 
e) The therapeutic efficacy and safety of the 
drugs can be improved by administering them as control-
led release or polymeric delivery systems for transder-
mal administration. 
f) Finally drug delivery systems can utilize elec-
tronic and computer technology to deliver the drug at a 
particular target in the body; for example, pulsed and/or 
self regulated drug delivery systems. 
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Table 1. EM related techniques used in characterizing and evaluating drug delivery systems (DDS). 
EM Technique Drug Delivery System References 
Scanning Electron 
Microscopy 
Microspheres 6, 8, 10, 12, 16, 17, 21, 27, 36, 38, 49, 50, 55, 57, 66, 73, 90, 
95, 110, 113, 115, 116, 137, 138, 141, 149, 156, 157, 161, 
162, 165' 166, 172, 173. 
Microcapsules 8, 15, 20, 23, 48, 63, 76, 77, 81, 82, 83, 93, 96, 102, 105, 
107, 109, 114, 119, 126, 134, 135, 139, 146, 147, 150, 151, 
152, 160, 170, 179, 181. 
Matrix Tablets 
Li po so mes 
Nanocapsules 
Polymeric Films 
28, 29, 68, 92, 98, 103, 112, 121, 180. 
45, 94, 118, 124, 132, 155, 176, 177. 
37, 46, 47, 91, 183. 
9, 11, 24, 26, 61, 69, 75, 86, 100, 120, 125, 130, 131, 133, 
140, 159, 167' 182. 
Miscellaneous 
Li po so mes 
Nanocapsules 
Polymeric 
Microcapsules 
Implants 
19, 25, 34, 41, 52, 67, 78, 79, 80, 99. 
Transmission Electron 
Microscopy 
2, 4, 132. 
3, 5, 13, 14, 111. 
11, 140. 
42, 77, 136, 142, 148, 174. 
72, 178. 
SEM with X-Ray 
Microanalysis 
Polymeric 
Matrix Carrier 
Micro spheres 
61, 75, 101, 130. 
56, 145. 
137. 
Freeze-fracture EM Liposomes 33, 44, 117, 122, 144, 155. 
Electron microscopic (EM) techniques have been 
used extensively in characterizing and/or evaluating var-
ious drug delivery systems. The purpose of the present 
paper is to review various EM techniques used for these 
purposes as well as to bring together different areas re-
lated to drug delivery systems in which EM techniques 
have been used to characterize and/or evaluate the sys-
tems (Table 1). EM techniques have been used to char-
acterize polymeric implantable delivery systems and 
some excipients used in the formulation of drug delivery 
systems in our laboratories. Application of scanning 
electron microscopy related techniques in drug delivery 
system formulation, development and evaluation can be 
classified in three phases: a) preformulation (Table 2); 
b) formulation and in vitro characterization (Table 3); c) 
in vivo evaluation and effectiveness (Table 4). 
Various EM related techniques used for this pur-
pose are given in Table 1, which includes scanning elec-
tron microscopy (SEM), transmission electron micros-
copy (TEM), SEM energy dispersive X-ray microanaly-
sis, and freeze-fracture electron microscopy. 
Applications of EM in preformulation stage 
Shape, surface, and particle size distribution of drug 
and excipient particles 
The shape, size, and surface characteristics of the 
drugs as well as the excipients significantly affect the 
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therapeutic efficacy of the drug delivery systems [135]. 
The drug incorporation, distribution, and release from 
the drug delivery systems, such as, controlled release 
matrix tablets [28, 29, 71], microcapsules [6, 102, 105], 
microspheres [12 , 115, 166], polymeric carriers [9, 24, 
159], are affected by the size and shape of drug-excipi-
ent particles. EM techniques have been used to study 
the surface properties of drugs particles [35, 37] and ex-
cipients [129, 140, 163] and to relate them to their use-
fulness in delivery systems. 
In our laboratories, maltodextrins (D-glucose 
saccharide polymers) for use as excipients in drug 
delivery formulations, have been characterized. Malto-
dextrins are non-sweet, nutritive saccharide polymers 
that consist of D-glucose units linked primarily by alpha 
1-4 bonds and have a dextrose equivalent (DE) value less 
than 20. We evaluated maltodextrins (normal, agglom-
erated, and superagglomerated with different DE 
values), as excipients in matrix based delivery systems 
[123]. The bulk density of various maltodextrins M-040 
(DE = 4), M-100 (DE= 10), M-150 (DE= 15), M-700 
(Superagglomerated M-100) was measured by tapping 10 
grams of the powder more than 100 times or until there 
was no change in volume. Flow properties were deter-
mined by the cone and funnel method and the angle of 
repose calculated (Table 5). Surface properties of 
maltodextrin derivatives were studied using SEM (Fig. 
1 for M-040 and Fig. 2 for M-150). It was observed 
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Table 2. SEM applications in preformulation stage of drug delivery systems. 
Parameter 
Shape, size and surface characterization of 
drug and excipients 
Particle size distribution 
Effect of Processing and formulation variables 
on drug delivery system characterization 
Mechanism of compression and deformation of particles 
Crystal structure and formation studies 
Granulation processing effect on particle surface 
Polymeric film studies 
Drug - Excipient Interaction 
Empty microcapsule/nanocapsule studies 
Mechanism oriented studies 
References 
35, 38, 55 , 62, 73 , 84, 88, 89, 94, 97, 98, 102, 107, 108, 
114-116, 128, 131, 134, 139, 143, 156, 163, 172, 181. 
23, 36, 49, 53, 90, 93, 102, 105, 151. 
10, 12, 14, 16, 17, 27, 30, 31, 32, 46, 48, 53, 59, 61, 63, 
81, 84 , 97, 103, 116, 124, 143, 156, 179. 
40, 51, 54, 129. 
51, 54, 129. 
35, 38, 39 , 54 . 
24, 56, 69, 103, 121, 140, 145, 174. 
39, 40. 
13, 17, 53, 58, 115. 
26, 29, 63 . 
Table 3. SEM applications in formulation and in vitro evaluation of drug delivery systems . 
Parameter 
Effect of drug loading on surface morphology 
of microspheres/nanocapsules 
Drug distribution, morphology, permeability, 
in vitro release in polymeric carriers 
Matrix tablet surface morphology and changes during in vitro release 
Physical structure of dry absorbed emulsions 
Liposomes: collagen gel matrix surface characterization 
Calcification of carriers/implant studies 
Mechanism of drug carrier formation, 
degradation and drug release mechanisms 
Reference 
16, 20, 25, 53, 63, 81, 84, 90, 93, 97, 104, 
105, 114, 115, 116, 122, 136, 139, 166, 173. 
56, 59, 61, 81, 84, 98, 100, 103, 112, 115, 
117, 119, 130, 132, 169, 172 . 
28, 29, 68, 121, 180, 182. 
19, 79, 80. 
99, 176. 
72, 75 , 99, 101, 158, 164, 175. 
15, 19, 28, 43, 53, 85, 97, 112, 113, 115, 
127' 130, 140, 167' 171. 
Table 4. SEM applications in characterizing and evaluating drug delivery systems in vivo. 
Parameter 
Effect of in vivo conditions on size, shape and surface of 
microcapsules and other drug delivery systems 
Ultra structural disposition/distribution 
Pathological effects of drugs released 
Blood-plasma compatibility of drug carriers 
Mechanism of drug penetration: corneal uptake, lymphatic uptake, etc. 
Bioerosion of drug delivery systems in body 
Mechanism of drug release 
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References 
42, 60, 65, 70, 71, 86, 87, 100, 133, 
144, 157, 161, 162, 168. 
42, 44, 47, 66, 74, 86, 155. 
7, 45, 66, 71, 86, 142, 178. 
1, 3, 11, 125, 168, 178. 
64, 178, 183. 
22, 43, 115, 157, 161, 170. 
65, 86. 
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Table 5. Micromeritic properties of maltodextrins 
Maltodextrin DE Bulk Angle of 
value density* g/ cc * derivative repose 
M-040 4 0.33 63° 
M-100 10 0.42 39° 
M-150 15 0.48 380 
M-700 10 0.15 36° 
*Average of three readings. 
that M-150 with DE value of 15 had many more elon-
gated particles than M-040 with DE value 4. These ex-
hibited different micromeritic and compressional proper-
ties when used as a directly compressible excipient in 
tablets [123]. A detailed report of the morphological 
characterization of maltodextrins using SEM and the cor-
relation with micromeritic properties is being published 
in this issue of Cells and Materials [153]. 
Effect of processing techniques on drug or excipient 
particles 
SEM has been used widely in studying particle 
properties and changes in surface characteristics during 
various processes like spheronization [88, 89], partial 
dissolution, swelling due to aqueous contacts, spray-
drying [90], granulation, and agglomeration [35, 38, 39, 
54]. SEM is a very effective tool in studying surfaces. 
In our studies of maltodextrins (Figs. 3 and 4), the ag-
glomeration process significantly increased the particle 
size and thus affected the bulk densities of these prod-
ucts' (Table 5). The low bulk density of M-700 can be 
attributed to the highly fluffy nature of these super ag-
glomerated products. Figs. 3 and 4 show the micro-
graphs of M-700 powders. It is observed that the ag-
glomeration process has led to the formation of bigger 
particles with large void volumes in the particles, there-
by decreasing the bulk density. The spherical particles 
are seen to attach to each other at one point. Every par-
ticle has an empty hollow space. The agglomeration 
process has increased the surface area enormously thus 
increasing the area of contact with other components 
such as air, moisture, and body fluids (when incorporat-
ed in drug delivery systems). 
The mechanism of compression and deformation of 
powders 
SEM techniques have been employed to study the 
mechanical properties of drug/excipient compacts [128], 
as well as the effect of compression on drug/excipient 
surface properties. The deformation of powders during 
compression and breaking has helped in understanding 
the mechanism of compression as well as the constitutive 
properties of matrix tablets which are one of the most 
widely used delivery systems for controlled release of 
drugs [39, 51, 54]. A study by Padmadisastra and 
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Gonda [129] showed that significant changes occurred in 
morphological properties of bagasse based microcrystal-
line cellulose (MCC) during compression. It was ob-
served that significant differences in the particle 
morphology of MCC from different sources affected the 
mean hardness, friability loss, and disintegration time of 
tablets prepared from these excipients. 
Drug crystal formation and structure 
Application of SEM in the preformulation stage of 
drug delivery systems is reported by Otsuka and 
Kaneniwa [128]. They studied the polymorphic transfor-
mation of chloramphenicol palmitate during the grinding 
process and have used SEM to characterize and identify 
the polymorphs and transformations in particle surface 
topography during processing. Another similar study 
has also reported the effect of compression on crystal 
structure [51]. A model has been developed to predict 
the uniaxial compaction behavior of compacts using the 
hardness and elastic moduli of brittle crystals determined 
by the Vickers microindentation test. SEM has been 
used to characterize the crystals and compacts during 
and after compression of acetaminophen, sucrose, and 
adipic acids. Electron micrographs of a fractured su-
crose compact showed substantial crushing at the asperi-
ties. The SEM observations supported the assumption 
that the fragments arising from crushing bear no load at 
lower relative densities [51]. 
Polymeric film casting and film studies 
SEM and TEM have been used to characterize 
polymeric films and castings of polymeric strips as drug 
carriers [18]. SEM has been used to give direct evi-
dence of the morphology differences among ethylcellu-
lose cast films with and without a drug [9]. Depending 
on the formulation and casting procedures, the film sur-
faces have been observed to be either smooth or rough 
with engulfed air pockets. TEM has been used in this 
study to reveal the influence of glass on the texture of 
samples [11]. It is reported that randomly distributed 
crystalline zones formed at the air side of the films 
which might account for the extreme heterogeneity of the 
films. Micrographs of the cross-section of films clearly 
indicated the heterogenous internal structure of the poly-
mer. Hsiue et al. [72] in their studies on the preparation 
and properties of poly(2-hydroxyethyl methacrylate) 
(PHEMA) grafted styrene-butadiene-styrene triblock co-
polymer (SBS) used SEM to characterize the surface 
morphology of copolymers with different degrees of 
grafting. They observed that the morphology of the sur-
face of the graft copolymer changed with the degree of 
grafting [72]. The vertical sections of the membrane 
showed a lower SBS layer and an upper PHEMA layer 
[11]. Bakker et al. [l l] studied the biocompatibility of 
two silicone rubber polymers and a polyurethane poly-
mer in vitro. Using SEM/TEM and quantitative analysis 
the epithelial morphology showed that polyurethanes and 
polyether-polyester copolymer have better biocompatibil-
ity than that of silastic rubber polymers [72]. 
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Figures 1-4. Scanning electron micrographs of maltodextrin M-040 (Fig. 1); M-150 (Fig. 2); and M-700 (Fig. 3 and 
4) powders. In Figure 4, one of the agglomerated particle is viewed showing spherical hollow particles agglomerated 
together. Bars = 100 µm (Figs. 1, 3 and 4) and 10 f'm (Fig. 2). 
Drug excipient interaction and characterization 
The interaction between drugs and excipients 
which are either inert additives, sustained release poly-
meric matrices, or films have been extensively studied 
by SEM [38, 39]. Our investigation of maltodextrins 
has shown that the agglomeration affected the excipient 
properties. The micrographs for M-040 (Fig. 1), M-150 
(Fig. 2), and M-700 (Fig 4) show the effects of agglom-
eration and superagglomeration on the particle shape and 
surface of maltodextrin. The M-700 powder had a low 
bulk density (Table 5) which correlated with hollow 
structures containing air pockets in the maltodextrin (see 
Fig. 3). A study of the drug loading mechanism in 
cross-linked polymers has been reported by Carli and 
Garbassi [34] using X-ray photoelectron spectroscopy. 
SEM also has been used to examine the surface char-
acteristics of drug excipient mixtures [39]. Figure 5 
shows a micrograph of griseofulvin-crospovidone matrix 
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system used as a drug carrier [34]. 
Empty microcapsule and nanocapsule studies 
SEM has been employed in studying the develop-
ment of empty microcapsule and nanocapsule formula-
tions using several polymers [ 13, 17]. Benita et al. [17] 
reported the preparation of carnauba wax microspheres 
with and without a drug (5-Fluorouracil) to show how 
various process parameters affect the preparation and 
properties of carnauba wax: 5-fluorouracil microspheres 
[17]. A similar study has been reported for nanocap-
sules [13]. The surface characterization of empty car-
riers has been performed SEM and TEM in both studies 
[13, 17]. These studies have been aimed at exploring 
the effects of various formulation and processing varia-
bles on surface, shape and size of microcapsules [53, 58] 
and microspheres [115]. TEM was found to be more 
useful for characterizing nanocapsule formulations [3, 5, 
13, 15, 111]. 
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SEM Applications in Formulation and In Vitro 
Characterization of Drug Delivery Systems 
Effect of drug loading 
The objectives of the formulator in designing drug 
delivery systems is to explore the possibility of adminis-
tering the desired amount of drug to the body. The de-
sired amount varied from drug to drug. Hence, incorpo-
ration of different amounts of drugs (drug loading) in 
drug carriers has been extensively studied in drug deliv-
ery systems. SEM and TEM have been employed in 
studying drug loading effects on microcapsules [106, 
107], microspheres [16, 110], nanocapsules [16, 46, 93], 
and polymeric film carriers [130, 131]. It was observed 
that the surface characteristics were significantly 
changed by the degree of drug loading. In one of our 
studies [12, 16] we have incorporated nifedipine in poly-
methacrylate microspheres with drug loadings from 5 to 
31 % and found that the smooth surface present at 5 % 
drug loading was gradually shifted to a very rough sur-
face at 31 % incorporation which affected the stability 
and in vitro drug release from these microspheres. In a 
study by Kawashima et al. [90] controlled release micro-
spheres have been prepared by a quasi emulsion solvent 
diffusion method for Ibuprofen. SEM has been used to 
study the surface topography of various microsphere for-
mulations depicting the differences in surface topogra-
phy with different polymers [90]. 
Drug distribution, morphology, permeability, and in 
vitro release in polymeric film carriers (matrices) 
Polymeric carriers are widely used, especially in 
the field of cardiovascular and contraceptive drug deliv-
ery systems. SEM is used for the study of drug distribu-
tion in the polymeric matrix, morphological characteri-
zation of matrices [61], permeability studies [11, 26, 
133], drug loading effects [100, 101], and surface char-
acterization during in vitro drug release studies [130, 
131]. We have used SEM in investigating drug distribu-
tion and surface morphology during release studies for 
verapamil polymeric carriers (154). Figures 6 and 7 
show the surface of films during pre- and post-release 
studies. It was observed that the drug had been uni-
formly distributed in the polymeric matrix. During the 
in vitro release process the particles swell and gradually 
leave the matrix forming holes and channels in the poly-
meric matrix surface (Fig. 7). A similar mechanism of 
release has also been observed in our other studies in 
which Fe3 +, Al3 +, or levamisole have been incorporated 
in polymeric carriers (polyurethane or silastic rubber 
polymers) for the prevention of heart valve calcification 
[130, 131]. 
Sustained release matrix tablets 
SEM has been used for characterizing surface 
properties of sustained release matrix tablets as well as 
studying the changes which occur in the tablet surface 
during release [71, 98]. Surface properties and uniform-
ity of film coating in coated tablets used for sustaining 
the drug release have been also characterized [28, 29]. 
56 
Emulsions 
Another interesting application of SEM has been 
in characterizing emulsions. Oral sustained release of 
drugs has been reported to be obtained by adsorbing the 
emulsion on silica. SEM was used to locate the drug 
crystals engulfed in the oil droplet adsorbed on silica 
particles [19]. SEM was also used in characterizing 
emulsions carrying microcapsules [80]. Microspheres 
containing multiple emulsions and coated emulsion parti-
cles with polysaccharides have been characterized using 
SEM. In a study of the coating of surfaces of oil in 
water (o/w) emulsions using polysaccharides bearing a 
cholesterol moiety, Iwamoto et al. [79] successfully used 
SEM to determine the shape, size, and surface properties 
of the emulsion systems (Fig. 8). 
Formulation, surface characterization of liposomes 
TEM [2, 5, 132] and freeze fracture electron mi-
croscopy [33, 44, 117] have been used extensively to 
characterize surface morphology of liposome-drug deliv-
ery systems [122]. TEM was used to study the bilayer 
structure of polymerized liposomes. TEM helped in re-
vealing that the polymerization reaction (between phos-
phatidyl choline vesicles stabilized by polycholesteryl 
methacrylate and carboxy methyl chitosan) increased the 
vesicle membrane stability [2]. Freeze fracture electron 
microscopy was employed in investigations of surface 
properties as well as drug incorporation studies [ 145, 
155]. Metha et al. [118] evaluated liposom·es containing 
amphotericin B for toxic and antifungal activities. Fig-
ure 9 shows a micrograph of liposomes. 
Calcification of drug carriers 
Calcification is a normal physiological phenome-
non. Several drug carriers, such as, polyurethane and 
hydro gels [75, 158] undergo calcification. Furthermore, 
bioprostheses based on either natural tissues or sypthetic 
polymers also undergo calcification [69, 99, 101]. SEM 
has been used to characterize the surface changes in the 
heart valve bioprosthesis due to the calcification process-
es when implanted in rats [146, 175]. 
Mechanism of drug carrier formation, degradation 
and drug release mechanism from biodegradable poly-
meric carriers 
SEM has been used in characterizing the forma-
tion of microcapsules and microspheres by such tech-
niques as polycondensation [8], coacervation [23, 48, 
107], or solvent evaporation [15, 106, 157]. The effect 
of processing and formulation variables on surface to-
pography was studied by SEM [20, 81, 82]. Microcap-
sule interactions with water or body fluids in vitro, and 
changes in their properties have been critically observed 
with the SEM [63, 76]. In the case of biodegradable 
polymeric carriers, the biodegradation during contact 
with body fluids was observed by SEM [53]. This 
helped in understanding the kinetics and mechanisms of 
biodegradation as well as of drug release from these 
carriers [85, 112, 113, 116]. TEM is reported to be 
useful in studying ultrastructural characterization of 
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Figure 5. Scanning electron micrograph of griseofulvin-crospovidone carrier system. (a) 1:5 w/w, bar= 10 µm; (b) 
1: 10 w/w, bar = 4 µm (from reference 34 with permission from the Amer. Pharmaceutical Association). 
Figure 6. Scanning electron micrograph of sustained release polymeric carriers (films) of verapamil, showing uniform 
distribution of drug in polymer film. Bar = 10 µm. 
Figure 7. Scanning electron micrograph of sustained release polymeric carrier (films) of verapamil during in vitro re-
lease studies after 3 weeks showing particle swelling and hole formation due to loss of drug particles during in vitro 
release studies. Bar = 10 µm. 
Figure 8. Scanning electron micrographs of (a) conventional and (b) CHE:200 = 1 :8 coated oil droplets in o/w emul-
sions on a filter paper. The CHM:200 coated droplets were prepared from 1 ml of conventional o/w lecithin emulsions 
and 7.2 mg CHM:200 = 1 :8; bars = 2 µm (from ref. 79 with permission from the Amer. Pharmaceutical Association) . 
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microcapsules and nanocapsules. The semipermeable 
membranes in microcapsules have been characterized by 
TEM [14, 41, 77, 174]. Another study reported the ap-
plication of SEM in studying the internal structure of 
polyamide microcapsules and the effect of irradiation on 
microcapsule surface properties [ 114]. Figures 10 and 
11 show the typical nanocapsule formulations viewed by 
TEM [4]. 
SEM Applications in Characterizing and 
Evaluating Drug Delivery Systems In Vivo 
Effect of in vivo conditions on size, shape, and surface 
of drug delivery systems 
In vivo interaction of various drug delivery sys-
tems, such as microcapsules [ 41, 144], micro spheres 
[ 65, 157, 162], liposomes [ 44, 45], and polymeric car-
riers, have been studied extensively using EM and other 
related techniques [70, 71, 86, 100, 133]. Biodegrada-
tion [46, 157], phagocytosis [161], uptake by body com-
partments such as liver, Kupffer cells, etc. has been ob-
served [45, 74]. Clayton et al. [41] studied the effect of 
capsule composition on the biocompatibility of alginate-
poly-1-lysine capsules. Empty capsules from high man-
nuronic acid alginate have been prepared and coated with 
poly-I-lysine alone, poly-I-lysine and guluronic acid and 
poly-I-lysine and high mannuronic acid alginate. The 
capsules have been placed in renal subcapsular space or 
the peritoneal cavity and retrieved after 3 weeks for his-
tological and electron microscopical study to evaluate in-
teraction of body cells and drug carriers as well as the 
fate of drug carriers in in vivo conditions. The infiltrat-
ing cells in the capsule surface have been characterized 
to be mostly fibroblasts and macrophages. Similar stud-
ies have also been reported [157, 170]. It is also report-
ed by Krause et al. [92] that liposomes formed aggre-
gates (when administered intravenously) during circula-
tion thus affecting the drug release. 
Ultrastructural disposition and distribution of carrier 
particles 
The uptake of the carrier particles in various body 
compartments [8, 45, 66], their distribution throughout 
the body [44, 46, 74], the accumulation [75], and ultra-
structural disposition has been studied using SEM. The 
microcapsules and nanocapsules administered orally [74] 
or by a parenteral route [157] have been monitored to 
study their distribution and accumulation in the body . 
SEM was found to be helpful in localizing these carriers 
in various tissues in the body [161]. Illum et al. [74] 
used SEM to study the distribution of model carrier par-
ticles (polystyrene microspheres) in the reticuloendothe-
lial system. Figures 12 and 13 show the accumulation of 
these microspheres in Kupffer cells [74]. 
Pathological effects of drugs 
Several research papers have reported the applica-
tion of EM techniques to the study of pathological ef-
fects of drugs released through drug delivery systems at 
the target site [8, 45, 66]. This has been an especially 
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useful in delivery system where accumulation of the drug 
carrier in cancer or body tissues releases the drug over 
sustained periods of time. The tissues have been charac-
terized using SEM for the pathological effects due to 
constantly released drug over longer periods of time [68, 
86]. The effects of drugs from a delivery system on cell 
structure have also been studied [144, 178], as part of in 
vivo evaluation of the carriers. 
Blood-plasma compatibility of drug carrier 
Delivery systems such as nanocapsules and lipo-
somes can be intravenously injected and can come in 
contact with blood-plasma components immediately after 
the injection. Their compatibility with circulating blood 
and its contents becomes of prime importance. Absolom 
et al. [l] studied the role that substrate surface proper-
ties play in influencing the extent of endothelialization 
of polymer surfaces during in vivo implantation and the 
interaction of body components with polymer carriers. 
Published micrographs show different degrees of endo-
thelialization for different polymer surfaces when ex-
posed to blood in vitro. Other similar reports have 
shown applications of EM techniques in studying the 
biocompatibility between drug carriers and blood, inter-
actions between them, and changes occurring during the 
contact time [11, 126, 168, 178]. 
Mechanism of drug penetration from drug delivery 
system 
Application of SEM is reported in understanding 
the mechanism of drug penetration in the cornea through 
ocular drug delivery systems [64]. Zimmer et al. [180], 
during their studies on the transport of PBCA nanoparti-
cles in ocular tissues, showed that the PBCA nanoparti-
cles penetration in eye tissue is limited to the precorneal 
area only. Penetration through tight junctions or 
through whole corneal tissue did not occur. They also 
studied the corneal sections by laser scanning confocal 
microscopy and suggested an uptake mechanism by 
phagocytosis [183]. 
SEM is also used to understand the mechanism of 
drug uptake through lymphatic systems. Williams et al. 
· [ 178] have reviewed the electron microscopy of endothe-
lial cell-biopolymeric interaction. 
Bioerosion of drug delivery systems in vivo 
The drug delivery systems based on biodegradable 
polymers such as pol yanh ydrides [ 113, 115, 116] or 
polycaprolactone [14] have been studied using SEM and 
the bioerosion of the carriers has been monitored [ 167]. 
SEM has been useful in understanding the mechanism of 
surface erosion of microspheres [42~ 116]. Brem et al. 
(22] studied the brain biocompatibility of a biodegrada-
ble controlled release polymer consisting of an anhy-
dride copolymer of fatty acid dimer and sebacic acid. 
The biodegradable carriers were implanted in the brain. 
The localized reaction evoked due to polymer implanta-
tion and bioerosion of drug carrier was monitored using 
EM techniques. The study showed an important applica-
tion of these polymers in delivering a water soluble drug 
by bypassing the blood-brain barrier. 
Evaluation of drug delivery systems by EM 
100nm 
----. 
Figure 9. Electron microscopic profiles of amphotericin 
B containing DPL vesicles. The size distribution of 
polymerized DPL vesicles is quite heterogenous as is 
typical for multilamellar vesicles. Large multilayered 
vesicles in the 2-4 µm size range are visible along with 
an abundant background of smaller vesicles. From re-
ference 118 with permission from the American Pharma-
ceutical Association . 
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Figure 10. Transmission electron micrograph of PLA 
nanocapsules prepared according to standard conditions 
by interfacial deposition of poly (D,L-lactide) polymer. 
From reference 5 with permission from the American 
Pharmaceutical Association. 
Figure 11. Transmission electron micrograph of PLA 
nanocapsules showing the presence of large multilamel-
lar phospholipid vesicles . From reference 5 with per-
mission from the American Pharmaceutical Association. 
Figure 12. Electron micrograph showing Kupffer cells 
situated between a sinusoid(s) and liver cells (L) 
following administration of 1013 polystyrene micro-
spheres of 359 nm diameter. The Kupffer cells are fill-
ed with the microspheres. From reference 74 with per-
mission from the American Pharmaceutical Association. 
Bar= 1 µm. 
Figure 13. Electron micrograph showing groups of par-
ticles (P) within a liver cells (L) 8 days following ad-
ministration of 1013 polystyrene microspheres of 359 nm 
diameter. c: bile canaliculus; m: mitochondrion; g: 
glycogen; r: rough endoplasmic reticulum. From refer-
ence 74 with permission from the American Pharmaceu-
tical Association. Bar = 1 µm . 
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Mechanism of drug release, absorption, phagocytosis 
and elimination in drug delivery systems 
SEM techniques have been used to study the in 
vitro - in vivo interaction of drug delivery systems such 
as microspheres [16, 65], microcapsules [20, 41], or 
nanocapsules [3 , 4] undergoing phagocytosis by macro-
phages [13]. The surface morphology of polymeric 
films in vivo after implantation has been studied by SEM 
and it is reported that the drug particles underwent 
swelling and were released from the surface forming 
holes and in time, channels [53] . Release mechanisms 
of biodegradable [81 , 84] or non-biodegradable micro-
spheres [12, 14] have been reported from a study of the 
surface topography during in vivo observations. Povey 
et al. [ 135] studied the delivery of chemical carcinogens 
with magnetic polyethyleneimine microcapsules by in 
vivo trapping of electrophiles from N-methyl-N-nitro-
sourea and recovery from feces. The mean diameter of 
administered and recovered microcapsules has been re-
ported to be different. The micrographs of these recov-
ered microcapsules showed the adsorption of particles of 
an unknown character as well as surface changes follow-
ing the in vivo exposure [135]. 
Conclusions 
Electron Microscopy techniques have been used 
extensively in characterizing and evaluating drug deliv-
ery systems . Due to the complex nature and microstruc-
ture of most of these delivery systems , EM is very use-
ful in understanding surface topography . It is used to 
study the effects of formulation and processing variables 
on the properties of drug delivery systems. It is also a 
very useful tool in the understanding of the mechanisms 
of a drug delivery system formation release, ultrastruc-
tural disposition and distribution , in vivo uptake and 
bioerosion. In the last few years, EM has achieved an 
indispensable status in drug delivery systems research , 
development, characterization and evaluation. 
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Discussion with Reviewers 
S.K. Williams: What drug delivery systems currently 
appear to be the most promising for the delivery of 
genetically engineered pharmaceuticals, particularly 
peptides and proteins? 
Authors: Currently, several drug delivery systems are 
being evaluated as carriers for proteins and peptides. 
Liposomes, stealth and immunoliposomes, nanocapsules, 
submicronized emulsions and polymeric carriers show 
promising applications for delivering specific proteins 
and peptides. None of them can be used generically for 
delivering proteins and peptides. Each has advantages 
and disadvantages when considered as carriers especially 
for proteins and peptides. 
M. Foldvari: Would you comment on the quantitative 
aspects of EM for pharmaceutical characterization pur-
poses? 
Authors: EM techniques can often be used to character-
ize particle size of pharmaceutical systems, especially 
when the dispersed phase has particles within nanometer 
range. Nanocapsules and nanospheres formulations are 
characterized by EM techniques. Quantitative character-
ization has become much easier and reproducible by 
laser beam analyses, which might be a technique of 
choice for scientists working in this area. 
